Search - tctmd.com

Displaying 301 - 319 of 319

Sort: Relevancy | Date

News Industry News

Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels

May 24, 2011

News Industry News

PROMUS Element™ Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study

May 20, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Industry News

Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System

April 25, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Industry News

Boston Scientific Announces its ACC 2011 Schedule

March 29, 2011

News Daily News

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

L.A. McKeown

March 10, 2011

News Industry News

Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System

March 06, 2011

News Industry News

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

February 16, 2011

News Conference News

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Caitlin E. Cox

February 15, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

News Industry News

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent

January 25, 2011

News Industry News

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

January 23, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

Jason Kahn

January 02, 2011

Advertisement

Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels

PROMUS Element™ Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

Boston Scientific Announces its ACC 2011 Schedule

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

TCTMD’s Top 10 Most Popular News Stories for 2010

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content